Satish K Tickoo
Overview
Explore the profile of Satish K Tickoo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
158
Citations
6254
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Samueli B, Al-Ahmadie H, Chen Y, Gopalan A, Sarungbam J, Tickoo S, et al.
Mod Pathol
. 2024 Sep;
38(1):100616.
PMID: 39326497
Gain-of-function isocitrate dehydrogenase (IDH) mutations are pathogenically significant in many tumor types and are actionable in cholangiocarcinoma, low-grade glioma, and acute myeloid leukemia. Rare IDH mutations have been described in...
2.
Mohanty S, Lobo A, Jha S, Sangoi A, Akgul M, Trpkov K, et al.
Virchows Arch
. 2024 Sep;
485(5):829-840.
PMID: 39287823
Oncocytic renal neoplasms are a major source of diagnostic challenge in genitourinary pathology; however, they are typically nonaggressive in general, raising the question of whether distinguishing different subtypes, including emerging...
3.
Baky F, Liso N, Williams B, Reuter V, Tickoo S, Feldman D, et al.
Urology
. 2024 Aug;
193:174-179.
PMID: 39128634
Objective: To review the presentation and long-term oncologic outcomes of patients with regressed ("burnt out") primary testicular germ cell tumors (GCT). Certain testicular GCT can present with complete regression of...
4.
Akbulut D, Whiting K, Teo M, Tallman J, Gokturk Ozcan G, Basar M, et al.
Mod Pathol
. 2024 Jul;
37(10):100557.
PMID: 38964503
Small cell carcinomas (SMC) of the lung are now molecularly classified based on the expression of transcriptional regulators (NEUROD1, ASCL1, POU2F3, and YAP1) and DLL3, which has emerged as an...
5.
Alghamdi M, Chen J, Jungbluth A, Koutzaki S, Palmer M, Al-Ahmadie H, et al.
Mod Pathol
. 2024 Mar;
37(5):100467.
PMID: 38460672
Renal low-grade oncocytic tumor (LOT) is a recently recognized renal cell neoplasm designated within the "other oncocytic tumors" category in the 2022 World Health Organization classification system. Although the clinicopathologic,...
6.
Nezami B, Modak S, Cardenas F, Sarungbam J, Sirintrapun S, Gopalan A, et al.
Pediatr Blood Cancer
. 2023 May;
70(8):e30434.
PMID: 37243318
Background: Ganglioneuroblastoma intermixed (GNBI) is classified as "favorable" histology by International Neuroblastoma Pathology Classification system. However, the International Neuroblastoma Risk Group (INRG) stratifies patients using wider clinicopathological and cytogenetic/molecular parameters....
7.
Fine S, Al-Ahmadie H, Vertosick E, Vickers A, Chen Y, Gopalan A, et al.
Urol Pract
. 2023 May;
9(5):459-465.
PMID: 37145713
Introduction: Our goal was to determine whether zonal origin of anterior dominant prostate cancers is associated with clinical outcome among patients treated with radical prostatectomy. Methods: We investigated the clinical...
8.
Espinosa-Cotton M, Guo H, Tickoo S, Cheung N
Front Oncol
. 2023 Apr;
13:1104693.
PMID: 37091153
Background: Development of successful antibody-based immunotherapeutic and radioimmunotherapeutic strategies rely on the identification of cell surface tumor-associated antigens (TAA) with restricted expression on normal tissues. Desmoplastic small round cell tumor...
9.
Warrick J, Hu W, Yamashita H, Walter V, Shuman L, Craig J, et al.
Nat Commun
. 2022 Dec;
13(1):7920.
PMID: 36564410
No abstract available.
10.
Warrick J, Hu W, Yamashita H, Walter V, Shuman L, Craig J, et al.
Nat Commun
. 2022 Nov;
13(1):6575.
PMID: 36323682
Cancers arising from the bladder urothelium often exhibit lineage plasticity with regions of urothelial carcinoma adjacent to or admixed with regions of divergent histomorphology, most commonly squamous differentiation. To define...